(Q45350949)

English

Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide

scientific article published in June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide (English)

1 reference

Europe PubMed Central

13 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

Toshiaki Yujiri

1

1 reference

Europe PubMed Central

13 December 2017

Mayumi Tanaka

2

1 reference

Europe PubMed Central

13 December 2017

Akihiko Taguchi

3

1 reference

Europe PubMed Central

13 December 2017

Yoshinori Tanaka

4

1 reference

Europe PubMed Central

13 December 2017

Yukinori Nakamura

5

1 reference

Europe PubMed Central

13 December 2017

Yukio Tanizawa

6

1 reference

Europe PubMed Central

13 December 2017

publication date

1 June 2013

1 reference

Europe PubMed Central

13 December 2017

Annals of Hematology

1 reference

Europe PubMed Central

13 December 2017

93

1 reference

Europe PubMed Central

13 December 2017

2

1 reference

Europe PubMed Central

13 December 2017

351-352

1 reference

Europe PubMed Central

13 December 2017

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1804-3

21 January 2018

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1804-3

21 January 2018

Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1804-3

21 January 2018

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1804-3

21 January 2018

Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1804-3

21 January 2018

Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1804-3

21 January 2018

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1804-3

21 January 2018

Identifiers

10.1007/S00277-013-1804-3

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45350949&oldid=2142455543"